Identification of Novel Alectinib-Resistant ALK Mutation G1202K with Sensitization to Lorlatinib: A Case Report and in silico Structural Modelling

BACKGROUND: Drug resistance caused by G1202R/G1202del mutation in anaplastic lymphoma kinase (ALK) represents a great challenge in the clinic. The effect of other mutation(s) at G1202 on the available tyrosine kinase inhibitors (TKIs) in the clinic remains unknown. CASE PRESENTATION: A 50-year-old C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ping, Cao, Ran, Bao, Hua, Wu, Xue, Yang, Lingling, Zhu, Dongqin, Zhang, Lu, Peng, Liming, Cai, Yuefei, Zhang, Weijun, Shao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007639/
https://www.ncbi.nlm.nih.gov/pubmed/33790576
http://dx.doi.org/10.2147/OTT.S293901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007639/
https://www.ncbi.nlm.nih.gov/pubmed/33790576
http://dx.doi.org/10.2147/OTT.S293901

Ejemplares similares